Efficacy of highly bioavailable oral curcumin in asymptomatic or mild COVID-19 patients: a double-blind, randomized, placebo-controlled trial.
| Publicado en: | Journal of Health, Population & Nutrition Vol. 43; no. 1; pp. 1 - 9 |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
BioMed Central
6/24/2024
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=178065269&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 178065269 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 16060997 HII jtl: Journal of Health, Population & Nutrition issn: 16060997 maglogo: N pubinfo: dt: 6/24/2024 vid: 43 iid: 1 pid: 24147 pub: BioMed Central artinfo: ui: 178065269 10.1186/s41043-024-00584-6 178065269 ppf: 1 ppct: 8 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Efficacy of highly bioavailable oral curcumin in asymptomatic or mild COVID-19 patients: a double-blind, randomized, placebo-controlled trial. aug: au: Kishimoto, Atsuhiro Komiyama, Maki Wada, Hiromichi Satoh-Asahara, Noriko Yamakage, Hajime Ajiro, Yoichi Aoyama, Hiroki Katsuura, Yasuhiro Imaizumi, Atsushi Hashimoto, Tadashi Sunagawa, Yoichi Morimoto, Tatsuya Kanai, Masashi Kakeya, Hideaki Hasegawa, Koji affil: Therabiopharma Inc., Kawasaki City, Kanagawa, Japan sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|